MS Speaks
Multiple Sclerosis => TREATMENTS => OCREVUS (ocrelizumab) => Topic started by: agate on September 25, 2020, 11:29:02 am
-
From PubMed (August 1, 2020), "Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study":
https://pubmed.ncbi.nlm.nih.gov/32727835/